AstraZeneca ditches lung cancer treatment trial
The FTSE 100 firm stopped a stage volrustomig drug trial a month after halting a trial for a new heart disease treatment.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.standard.co.uk — the content belongs to Evening Standard.
